Teva Pharmaceutical Industries Limited (TEVA)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$32.29
-1.76%
Mkt Cap $36.69B
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$38.33
Range $35.00 – $41.00
Implied Upside
+18.7%
Consensus $38.33 vs current $32.29